Mictonorm Xl (Propiverine Hydrochloride)

Propiverine Hydrochloride, the active ingredient in Mictonorm XL, is an antimuscarinic presented as an extended‑release tablet for oral administration. It is indicated for the management of overactive bladder, reducing urinary frequency, urgency symptoms and urgency urinary incontinence in adult patients. The formulation provides a steady plasma concentration over 24 hours, improving bladder storage function and patient adherence.

GNH USA supplies Mictonorm XL as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company emphasizes quality assurance and regulatory compliance in all shipments.

Propiverine Hydrochloride is an antimuscarinic agent that acts on the detrusor muscle to manage disorders of bladder storage, particularly those characterized by involuntary contractions.

- Overactive bladder: reduces urgency, frequency and incontinence episodes, enhancing daily comfort. - Urinary frequency: decreases the number of daily voids, helping patients achieve longer intervals between bathroom visits. - Urgency urinary incontinence: improves continence by limiting involuntary bladder contractions, reducing leak episodes. - Nocturia: lessens nighttime awakenings due to bladder activity.

Propiverine may cause several adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry mouth: reduced salivary flow. - Constipation: slowed gut motility. - Headache: mild to moderate pain. - Dizziness: feeling of light‑headedness.

Serious or Rare Side Effects: - Acute urinary retention: inability to empty bladder. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Tachycardia: rapid heart rate. - Glaucoma exacerbation: increased intra‑ocular pressure.

When prescribing Propiverine, clinicians should consider several precautionary measures to ensure safe use.

- Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate hepatic status: monitor liver enzymes in patients with liver disease. - Review cardiac history: use cautiously in patients with arrhythmias or tachycardia. - Caution in narrow‑angle glaucoma: antimuscarinic effect may worsen intra‑ocular pressure. - Avoid in urinary retention: may exacerbate inability to void. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Propiverine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma levels, risking toxicity. - Anticholinergic burden: concurrent antimuscarinics can amplify side effects like dry mouth and constipation.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin): may reduce effectiveness. - Digoxin: may increase risk of arrhythmias. - Antihistamines with anticholinergic activity: may enhance antimuscarinic effects. - Alcohol: can increase dizziness and sedation.